Silverfin false false 30/04/2025 01/05/2024 30/04/2025 Dr C J Burrell 16/04/2015 Mrs E Burrell 16/04/2015 09 January 2026 The principal activity of the Company during the financial year was medical consultancy. 09546601 2025-04-30 09546601 bus:Director1 2025-04-30 09546601 bus:Director2 2025-04-30 09546601 core:CurrentFinancialInstruments 2025-04-30 09546601 core:CurrentFinancialInstruments 2024-04-30 09546601 2024-04-30 09546601 core:ShareCapital 2025-04-30 09546601 core:ShareCapital 2024-04-30 09546601 core:RetainedEarningsAccumulatedLosses 2025-04-30 09546601 core:RetainedEarningsAccumulatedLosses 2024-04-30 09546601 core:OtherPropertyPlantEquipment 2024-04-30 09546601 core:OtherPropertyPlantEquipment 2025-04-30 09546601 bus:OrdinaryShareClass1 2025-04-30 09546601 bus:OrdinaryShareClass2 2025-04-30 09546601 2024-05-01 2025-04-30 09546601 bus:FilletedAccounts 2024-05-01 2025-04-30 09546601 bus:SmallEntities 2024-05-01 2025-04-30 09546601 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 09546601 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 09546601 bus:Director1 2024-05-01 2025-04-30 09546601 bus:Director2 2024-05-01 2025-04-30 09546601 core:OtherPropertyPlantEquipment core:TopRangeValue 2024-05-01 2025-04-30 09546601 2023-05-01 2024-04-30 09546601 bus:OrdinaryShareClass1 2024-05-01 2025-04-30 09546601 bus:OrdinaryShareClass1 2023-05-01 2024-04-30 09546601 bus:OrdinaryShareClass2 2024-05-01 2025-04-30 09546601 bus:OrdinaryShareClass2 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 09546601 (England and Wales)

# DR C J BURRELL LIMITED

### Unaudited Financial Statements
For the financial year ended 30 April 2025
Pages for filing with the registrar

DR C J BURRELL LIMITED

## Unaudited Financial Statements

For the financial year ended 30 April 2025

Contents

DR C J BURRELL LIMITED

## BALANCE SHEET

As at 30 April 2025
DR C J BURRELL LIMITED

## BALANCE SHEET (continued)

As at 30 April 2025

| Note | 2025 |  | 2024
|  | £ |  | £
Current assets |  |  |  |
Debtors | 4 | 8,344 |  | 0
Cash at bank and in hand |  | 2,380 |  | 3,882
|  | 10,724 |  | 3,882
Creditors: amounts falling due within one year | 5 | ( 2,993) |  | ( 2,383)
Net current assets |  | 7,731 |  | 1,499
Total assets less current liabilities |  | 7,731 |  | 1,499
Net assets |  | 7,731 |  | 1,499
Capital and reserves |  |  |  |
Called-up share capital | 6 | 2 |  | 2
Profit and loss account |  | 7,729 |  | 1,497
Total shareholders' funds |  | 7,731 |  | 1,499

For the financial year ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Dr C J Burrell Limited (registered number: 09546601) were approved and authorised for issue by the Board of Directors on 09 January 2026. They were signed on its behalf by:

Dr C J Burrell Director |

DR C J BURRELL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2025
DR C J BURRELL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Dr C J Burrell Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Melville Building East, Royal William Yard, Plymouth, PL1 3RP, United Kingdom. The principal place of business is North Fursdon, Yealmpton, Plymouth, Devon, PL8 2EN.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery etc. | 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including directors | 0 |  | 1

#### 3. Tangible assets

| Plant and machinery etc. |  | Total
| £ |  | £
Cost |  |  |
At 01 May 2024 | 190 |  | 190
At 30 April 2025 | 190 |  | 190
Accumulated depreciation |  |  |
At 01 May 2024 | 190 |  | 190
At 30 April 2025 | 190 |  | 190
Net book value |  |  |
At 30 April 2025 | 0 |  | 0
At 30 April 2024 | 0 |  | 0

#### 4. Debtors

| 2025 |  | 2024
| £ |  | £
Other debtors | 8,344 |  | 0

#### 5. Creditors: amounts falling due within one year

| 2025 |  | 2024
| £ |  | £
Corporation tax | 1,697 |  | 839
Other creditors | 1,296 |  | 1,544
| 2,993 |  | 2,383

#### 6. Called-up share capital

| 2025 |  | 2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
1 Ordinary A share of £ 1.00 | 1 |  | 1
1 Ordinary B share of £ 1.00 | 1 |  | 1
| 2 |  | 2

#### 7. Related party transactions

Transactions with the entity's directors

| 2025 |  | 2024
| £ |  | £
Amount advanced to directors | 8,344 |  | (344)

During the year advances amounting to £15,000 and repayments amounting to £6,312 were made.